STIGALL L. JEREMY bought CLPT
March 11, 2026 · Form 4 insider transaction
STIGALL L. JEREMY bought 8,291 shares of ClearPoint Neuro, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,291
Price
N/A
Total value
N/A
InsiderSTIGALL L. JEREMY
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 11, 2026
Filing dateMarch 13, 2026
Shares owned after95,862
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.